Simon N.R. Harford
CIK 1443705 · Chief Financial Officer · last filed 2026-04-27
Simon N.R. Harford is a Chief Financial Officer who has filed 38 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing shows the insider disposed of $2.1M of FOLD on Apr 27, 2026. Across all open-market trades the lifetime net is −$138.7K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
38
-$138.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Chief Financial Officer | 0 | $14.49 | $0 | $0 | 7 | 2026-04-27 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | CFO and Treasurer | 0 | $44.15 | $0 | -$138.7K | 27 | 2023-03-02 |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | SVP & Chief Financial Officer | 10,736 | — | — | $0 | 1 | 2017-05-10 |
| AVON PRODUCTS INC (AVP) Delisted | Grp. VP & Corp. Controller | — | — | — | $0 | 2 | 2009-03-09 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-27 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Disp (D) | −143,595 | -$2.08M | EDGAR |
| 2025-12-30 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −71,303 | -$1.02M | EDGAR |
| 2025-08-25 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −12,529 | -$95.2K | EDGAR |
| 2025-01-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +75,591 | -$69.7K | EDGAR |
| 2024-08-23 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −12,529 | -$151.5K | EDGAR |
| 2024-01-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +57,392 | $0 | EDGAR |
| 2023-08-23 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +106,973 | $0 | EDGAR |
| 2023-03-02 | ALBIREO PHARMA, INC. (ALBO) Delisted | Mixed | −13,739 | $0 | EDGAR |
| 2023-01-27 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +55,000 | $0 | EDGAR |
| 2023-01-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +55,000 | $0 | EDGAR |